ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.

Antonello, Paola; Pizzagalli, Diego U; Foglierini, Mathilde; Melgrati, Serena; Radice, Egle; Thelen, Sylvia; Thelen, Marcus (2023). ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production. Frontiers in immunology, 13(1067885), p. 1067885. Frontiers Research Foundation 10.3389/fimmu.2022.1067885

[img]
Preview
Text
fimmu-13-1067885.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (15MB) | Preview

Chemotaxis is an essential physiological process, often harnessed by tumors for metastasis. CXCR4, its ligand CXCL12 and the atypical receptor ACKR3 are overexpressed in many human cancers. Interfering with this axis by ACKR3 deletion impairs lymphoma cell migration towards CXCL12. Here, we propose a model of how ACKR3 controls the migration of the diffused large B-cell lymphoma VAL cells in vitro and in vivo in response to CXCL12. VAL cells expressing full-length ACKR3, but not a truncated version missing the C-terminus, can support the migration of VAL cells lacking ACKR3 (VAL-ko) when allowed to migrate together. This migration of VAL-ko cells is pertussis toxin-sensitive suggesting the involvement of a Gi-protein coupled receptor. RNAseq analysis indicate the expression of chemotaxis-mediating LTB4 receptors in VAL cells. We found that LTB4 acts synergistically with CXCL12 in stimulating the migration of VAL cells. Pharmacologic or genetic inhibition of BLT1R markedly reduces chemotaxis towards CXCL12 suggesting that LTB4 enhances in a contact-independent manner the migration of lymphoma cells. The results unveil a novel mechanism of cell-to-cell-induced migration of lymphoma.

Item Type:

Journal Article (Original Article)

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

ISSN:

1664-3224

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Pubmed Import

Date Deposited:

31 Jan 2023 13:04

Last Modified:

05 Feb 2023 02:26

Publisher DOI:

10.3389/fimmu.2022.1067885

PubMed ID:

36713377

Uncontrolled Keywords:

ACKR3 CXCR4 CXCR5 atypical chemokine receptor chemokine leukotriene B4 lymphoma characters

BORIS DOI:

10.48350/178132

URI:

https://boris.unibe.ch/id/eprint/178132

Actions (login required)

Edit item Edit item
Provide Feedback